Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Design Therapeutics (DSGN)
NASDAQ:DSGN
Holding DSGN?
Track your performance easily
Design Therapeutics (DSGN) Ownership Overview
19.36% Insiders
5.11% Mutual Funds
34.25% Other Institutional Investors
36.04% Public Companies and
Individual Investors
The ownership structure of Design Therapeutics (DSGN) stock is a mix of institutional, retail and individual investors. Approximately 39.37% of the company’s stock is owned by Institutional Investors, 19.36% is owned by Insiders and 36.04% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 12, 2024 | William Arsani Director | xxxxxxxxxxxxx | $3463215 |
| Mar 25, 2024 | John Schmid Director | xxxxxxxxxxxxx | $99659 |
| Mar 25, 2024 | Heather A. Berger Director | xxxxxxxxxxxxx | $4862 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $5679234 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,695,294 | Institution | 2.99% | 8,476,470 | |
| 1,390,134 | Institution | 2.46% | 6,950,670 | |
| 1,350,409 | Institution | 2.39% | 6,752,045 | |
| 1,185,921 | Institution | 2.09% | 5,929,605 | |
| 957,005 | Institution | 1.69% | 4,785,025 | |
| 390,858 | Institution | 0.69% | 1,954,290 | |
| 359,435 | Institution | 0.63% | 1,797,175 | |
| 275,438 | Institution | 0.49% | 1,377,190 | |
| 257,666 | Institution | 0.46% | 1,288,330 | |
| 250,666 | Institution | 0.44% | 1,253,330 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,390,134 | Institution | 2.46% | 6,950,670 | |
| 957,005 | Institution | 1.69% | 4,785,025 | |
| 390,858 | Institution | 0.69% | 1,954,290 | |
| 359,435 | Institution | 0.63% | 1,797,175 | |
| 275,438 | Institution | 0.49% | 1,377,190 | |
| 257,666 | Institution | 0.46% | 1,288,330 | |
| 250,666 | Institution | 0.44% | 1,253,330 | |
| 224,300 | Institution | 0.40% | 1,121,500 | |
| 192,570 | Institution | 0.34% | 962,850 | |
| 146,718 | Institution | 0.26% | 733,590 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 813,428 | Institution | 1.44% | 3,839,380 | |
| 800,901 | Institution | 1.41% | 3,804,280 | |
| 399,505 | Institution | 0.71% | 1,897,649 | |
| 292,015 | Institution | 0.52% | 1,460,075 | |
| 141,110 | Institution | 0.25% | 666,039 | |
| 126,408 | Institution | 0.22% | 600,438 | |
| 71,484 | Institution | 0.13% | 337,404 | |
| 68,640 | Institution | 0.12% | 323,981 | |
| 55,239 | Institution | 0.10% | 262,385 | |
| 32,737 | Institution | 0.06% | 154,519 |
FAQ
Who Owns Design Therapeutics (DSGN)?
According to the latest TipRanks data, approximately 34.25% of the company's stock is held by institutional investors, 19.36% is held by insiders, and 36.04% is held by retail investors.
What percentage of Design Therapeutics (DSGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 34.25% of Design Therapeutics (DSGN) stock is held by institutional investors.
What percentage of Design Therapeutics (DSGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.04% of Design Therapeutics (DSGN) stock is held by retail investors.
Who owns the most shares of Design Therapeutics (DSGN)?
Felix Baker owns the most shares of Design Therapeutics (DSGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.